Citadel Advisors’s China Pharma Holdings CPHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.88K | Buy |
+12,924
| New | +$10.9K | ﹤0.01% | 12783 |
|
|
2025
Q4 | – | Sell |
-30,426
| Closed | -$59.3K | – | 12821 |
|
|
2025
Q3 | $59.3K | Buy |
30,426
+7,356
| +32% | +$12.5K | ﹤0.01% | 12107 |
|
|
2025
Q2 | $41.3K | Buy |
23,070
+17,764
| +335% | +$32.6K | ﹤0.01% | 11863 |
|
|
2025
Q1 | $14K | Buy |
+5,306
| New | +$12.1K | ﹤0.01% | 13384 |
|
|
2024
Q2 | – | Sell |
-9,430
| Closed | -$35K | – | 14385 |
|
|
2024
Q1 | $35K | Buy |
9,430
+6,106
| +184% | +$26.8K | ﹤0.01% | 12534 |
|
|
2023
Q4 | $20.1K | Buy |
+3,324
| New | +$18.6K | ﹤0.01% | 12612 |
|
|
2022
Q3 | – | Sell |
-70
| Closed | -$7K | – | 12739 |
|
|
2022
Q2 | $7K | Buy |
+70
| New | +$9.37K | ﹤0.01% | 12646 |
|
|
2021
Q3 | – | Sell |
-92
| Closed | -$33K | – | 13881 |
|
|
2021
Q2 | $33K | Sell |
92
-177
| -66% | -$63.6K | ﹤0.01% | 13458 |
|
|
2021
Q1 | $113K | Buy |
269
+245
| +1,021% | +$106K | ﹤0.01% | 12360 |
|
|
2020
Q4 | $5K | Sell |
24
-173
| -88% | -$37.2K | ﹤0.01% | 10835 |
|
|
2020
Q3 | $36K | Buy |
+197
| New | +$45.5K | ﹤0.01% | 9706 |
|
|
2020
Q2 | – | Sell |
-44
| Closed | -$11K | – | 9853 |
|
|
2020
Q1 | $11K | Sell |
44
-8
| -15% | -$2.11K | ﹤0.01% | 9406 |
|
|
2019
Q4 | $6K | Sell |
52
-147
| -74% | -$18.1K | ﹤0.01% | 9019 |
|
|
2019
Q3 | $24K | Buy |
+199
| New | +$27.2K | ﹤0.01% | 8895 |
|
|
2018
Q4 | – | Sell |
-122
| Closed | -$12K | – | 9178 |
|
|
2018
Q3 | $12K | Hold |
122
| – | – | ﹤0.01% | 9090 |
|
|
2018
Q2 | $13K | Sell |
122
-178
| -59% | -$24K | ﹤0.01% | 8706 |
|
|
2018
Q1 | $48K | Buy |
300
+225
| +300% | +$40.2K | ﹤0.01% | 7932 |
|
|
2017
Q4 | $7K | Sell |
75
-237
| -76% | -$20.6K | ﹤0.01% | 7903 |
|
|
2017
Q3 | $27K | Buy |
312
+246
| +373% | +$24.4K | ﹤0.01% | 7306 |
|
|
2017
Q2 | $8K | Sell |
66
-27
| -29% | -$3.05K | ﹤0.01% | 7380 |
|
|
2017
Q1 | $12K | Buy |
93
+61
| +191% | +$7.74K | ﹤0.01% | 7327 |
|
|
2016
Q4 | $4K | Buy |
+32
| New | +$3.4K | ﹤0.01% | 7167 |
|
|
2016
Q3 | – | Sell |
-174
| Closed | -$21K | – | 7284 |
|
|
2016
Q2 | $21K | Buy |
+174
| New | +$19.5K | ﹤0.01% | 6585 |
|
|
2016
Q1 | – | Sell |
-54
| Closed | -$4K | – | 6925 |
|
|
2015
Q4 | $4K | Buy |
54
+32
| +145% | +$3.1K | ﹤0.01% | 8483 |
|
|
2015
Q3 | $2K | Sell |
22
-62
| -74% | -$7.52K | ﹤0.01% | 8729 |
|
|
2015
Q2 | $15K | Buy |
+84
| New | +$14.4K | ﹤0.01% | 8283 |
|
|
2014
Q4 | – | Sell |
-48
| Closed | -$6K | – | 8511 |
|
|
2014
Q3 | $6K | Sell |
48
-135
| -74% | -$19.4K | ﹤0.01% | 7869 |
|
|
2014
Q2 | $35K | Sell |
183
-48
| -21% | -$9.98K | ﹤0.01% | 6980 |
|
|
2014
Q1 | $58K | Buy |
231
+143
| +163% | +$39.5K | ﹤0.01% | 6646 |
|
|
2013
Q4 | $15K | Buy |
+88
| New | +$14.8K | ﹤0.01% | 6595 |
|
Other funds holding CPHI
EI
DB
Citadel Advisors's CPHI Position: Q1 2026 in Review
Citadel Advisors opened a new position in China Pharma Holdings (CPHI) in Q1 2026: 12,924 shares worth $7.88K. The stake represents ﹤0.01% of the portfolio and ranks #12783 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in CPHI as recently as Q3 2025.
Citadel Advisors first reported a position in CPHI in Q4 2013 and has held it in 30 quarters since. The position peaked at $113K in Q1 2021. 6 funds tracked by Wall St. Rank hold CPHI as of Q1 2026.
- Citadel Advisors held 12,924 shares of China Pharma Holdings worth $7.88K as of Q1 2026.
- China Pharma Holdings was a new Citadel Advisors position in Q1 2026.
- China Pharma Holdings made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12783 holding.
- Citadel Advisors first reported a position in China Pharma Holdings in Q4 2013 and has held it in 30 quarters since.
- Citadel Advisors's China Pharma Holdings position peaked at $113K in Q1 2021.
- 6 funds tracked by Wall St. Rank held China Pharma Holdings as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.